Allogene reports 58% disease clearance rate in lymphoma trial
Go back to Allogene reports 58% disease clearance rate in lymphoma trial| (NASDAQ: ALLO) | Delayed: 2.10 +0.10 (5.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.00 | 52 Week High | $ | |||
| Open | $2.03 | 52 Week Low | $ | |||
| Day High | $2.18 | P/E | N/A | |||
| Day Low | $2.01 | EPS | $ | |||
| Volume | 6,571,889 | |||||
